Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

Change Symbol: Lookup Trade Now

AEterna Zentaris | Company Snapshot

  • Vol:
  • Last Trade:

AETERNA ZENTARIS INC.

AETERNA ZENTARIS INC. is a global biopharmaceutical company focused on endocrine therapy and oncology with expertise in drug discovery, development and commercialization.


Symbol: AEZ
Exchange(s): Toronto Stock Exchange
Industry: Consumer Products (Biotechnology & Pharmaceuticals)
5-Star Rating:
ANNUAL FINANCIALS
  Dec 31, 2008
12 Months
us$
Dec 31, 2007
12 Months
us$
Dec 31, 2006
12 Months
us$
3Yr.
Growth
% Change
Total Revenue ($000) 42,417 43,944 42,543 -8.29
Earnings before Interest & Tax ($000) -58,445 -33,913 -20,027 N/A
Profit/Loss ($000) -59,817 -32,296 33,390 N/A
Earnings per Share -1.12 -0.61 0.64 N/A
Total Assets ($000) 108,342 123,363 223,491 -35.01
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity -110.64 -23.46 22.72  
Employees 109 140 150  
 
Trailing 12 Month Results
  12 Months ended
Sep 30, 2009, us$
12 Months ended
Sep 30, 2008, us$
%Change
Total Revenue ($000) 34,333 45,001 -12.04
Profit/Loss ($000) -51,249 -58,960 -0.54
Earnings per Share -0.93 -1.11 1.70
Dividends Per Share 0.00 0.00
Number of Shares 58,506,619 53,187,470  
 
COMPANY INFORMATION
Report on Business Magazine Top 1000 Ranking
Profit: 0900 Revenue: 0658 Assets:  0655  
 
Key Personnel
CEO: Juergen Engel, President & C.E.O.
CFO: Dennis Turpin, S.V.P. & C.F.O.
 
Contact Information
Address: 1405 du Parc Technologique Blv,
Quebec,
QC,
G1P 4P5
Phone: 418-652-8525
Fax: 418-652-0881
Web Address: www.aezsinc.com
E-Mail : aeternazentaris@aezsinc.com
Investor Relations: Ginette Vallieres, 418-652-8525
 
Company Type: Public Company Status: Active
Auditors: Pricewaterhousecoopers Llp
Transfer Agent: Computershare Trust Co. Of Can
Incorporation: Cbca, Sep 12, 1990
 
Securities: AEZS-Q AEZ-T
 
Top Companies in Biotechnology & Pharmaceuticals (Selected by Assets)
Biovail Patheon Inc. Atrium Innovations
QLT Inc. Angiotech Pharmaceuticals Cangene Corp.
Futuremed Healthcare Paladin Labs Inc LAB Research
 


All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.


Back to top